TOPIC2023 was held at Cerulean Tower Tokyo from July 13th to 15th, 2023.

　

Our hospital held a live demonstration of open vessel complex PCI on July 13th, and a live demonstration of CTO cases only on July 15th.

　

With the cooperation of all our staff, we were able to secure a total of 13 cases and hold the event without any problems, so we are relieved that we were able to do so without any problems. At the same time, we would like to express our sincere gratitude to all those involved who helped us.

　

The Complex open vessel PCI live event held on July 13th was the first of its kind for TOPIC, and we took great care in selecting cases and surgeons for the event.

　

On the day, a total of six cases were treated by Dr. Yoshifumi Kashima of the Sapporo Cardiovascular Clinic, Dr. Naoe Isomura of Showa University Northern Hospital, Dr. Shinya Okazaki of Juntendo University, Dr. Fumitoshi Hosaka of Okamura Memorial Hospital, and Dr. Masakazu Tsutsumi of Saiseikai Yokohamashi Tobu Hospital (our hospital).

　

This is my personal opinion, but I think that the calcified lesions were quite difficult and the surgeons had a hard time treating them. In addition, in the two cases where DCA was performed, the targeted debulking was successful, in one case a stent was placed after making a landing for the stent, and in the other case treatment was completed with DCA alone. I think this was the first time that DCA was properly performed at TOPIC.

　

We believe that each of the live cases provided a very fruitful opportunity for discussion.

　

Ultimately, all cases, including preliminary cases, were successfully treated without any complications.

　

On July 15th, we held a live performance featuring only CTO cases.

　

A total of five doctors, including Dr. Yasushi Asakura of Aqua Rehabilitation Hospital, who is the representative organizer of TOPIOC, Dr. Takayuki Ogawa of the Jikei University School of Medicine, and Dr. Ito from our hospital, as well as guests Dr. Yuji Oikawa of the Cardiovascular Research Institute and Dr. Masaki Fujita of Edogawa Hospital, attempted to treat seven cases of CTO.

　

Complex CTO treatment was performed using various techniques, including antegrade wiring, kissing wiring (after retrograde wiring), and IVUS-guided tip detection intraplaque trucking, and the CTO lesion was successfully patented and reperfused in all patients.

　

In a high-risk case treated by Ito, in which the entire procedure was not completed, the CTO was successfully passed using antegrade GWE, and the LAD just proximal was debulked using DCA, avoiding cross-over stents from LMT and placing a stent only in the occluded CTO area, completing the treatment.

　

More than 1,000 people attended the event, and I understand that the event was a great success. I feel a sense of relief that the two major events held at our hospital in the first half of the year (the first being the Yokohama Live Demonstration) have come to an end.

　

The second half of the year is packed with live events, starting with the CVIT live, followed by the SAMURAI live demonstration, DCA live demonstration, CTO summit, and Jcalc2024.

　

The coronavirus has now been classified as Class 5, and we will continue to spend each day praying that we will return to pre-coronavirus normality, so we ask for the continued participation and cooperation of all those involved.

　

　

　

　

　

Yokohama Live Demonstration Study Group (medical-convention.com)